Juvenile idiopathic arthritis treatment market was valued at $3.0 billion in 2023 and is projected to reach $5.8 billion by 2035, growing at a CAGR of 6.1% during the forecast period (2025-2035). The JIA therapeutic industry growth is driven by the high prevalence of juvenile idiopathic arthritis, the growing adoption of innovative drug delivery technologies, […]
Tag Archives: Juvenile Idiopathic Arthritis Treatment Market
The Global Juvenile Idiopathic Arthritis Treatment Market is anticipated to gain exponential industry growth over the given forecast period of 2022-2028. JIA, also known as juvenile idiopathic arthritis, is the most common inflammatory arthritis of childhood and musculoskeletal pain is a common symptom in childhood and is usually benign and self-limiting. JIA affects children under […]